Dr. Edgardo Santos' Interview with Mariana Chavez-McGregor, MD, MSc, FASCO
Update: 2025-08-25
Description
Interviews with Summit Director Edgardo S. Santos Castillero, MD, FACP, FASCO at NOSCM 2024 | New Orleans SummerCancer Meeting
Dr. Edgardo Santos' Interview with Mariana Chavez-McGregor, MD, MSc, FASCO
Dr. Chavez-McGregor discusses endocrine and targeted therapies for hormone-positive, HER2-negative breast cancer patients highlighting the importance of individualized therapy due to new drugs and evolving algorithms. She notes the challenge of sequencing treatments, as clinical trials often compare drugs in isolation, while patients receive treatments sequentially. Additionally, she discusses the early use of new molecules in high-risk early-stage breast cancer and the need for further research to address these complexities.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
